Literature DB >> 22469603

The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification.

Antonio Valero1, Rosa Muñoz-Cano, Joaquín Sastre, Ana M Navarro, Enrique Martí-Guadaño, Ignacio Dávila, Alfonso del Cuvillo, Carlos Colás, Ignacio Antépara, Iñaki Izquierdo, Joaquim Mullol.   

Abstract

INTRODUCTION: Allergic rhinitis (AR) is a common disease with major socieconomic burden and a significant impact on quality of life.
OBJECTIVE: The objective of the study was to assess the impact of AR severity, using the modified ARIA (m-ARIA) severity criterion in order to discriminate among moderate and severe AR, in symptoms and quality of life assessed with the questionnaire ESPRINT-15.
METHODS: The specific quality of life questionnaire (ESPRINT-15) was applied in over thousand untreated RA patients. Severity was evaluated by the m-ARIA classification, which categorizes AR as mild, moderate, and severe. Nasal symptoms were evaluated by using categorized (none, low, middle, and high) Total Four Symptom Score (T4SS).
RESULTS: Using the m-ARIA severity classification, significant differences in quality of life, both global score and specific domains, and categorized T4SS were found among the AR severity groups.
CONCLUSION: Modified ARIA severity classification in mild, moderate, and severe allergic rhinitis clearly discriminates the impact of AR in all domains of quality of life and categorized symptom`s score.

Entities:  

Mesh:

Year:  2012        PMID: 22469603     DOI: 10.4193/Rhino.11.071

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  9 in total

1.  When perennial rhinitis worsens: rhinolith mimicking severe allergic rhinitis.

Authors:  Enrico Heffler; Giacomo Machetta; Mauro Magnano; Giovanni Rolla
Journal:  BMJ Case Rep       Date:  2014-02-13

Review 2.  Comparative analysis of allergic rhinitis in children and adults.

Authors:  Adriana Izquierdo-Domínguez; Antonio L Valero; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

3.  Assessment of disease control in allergic rhinitis.

Authors:  Pascal Demoly; Moises A Calderon; Thomas Casale; Glenis Scadding; Isabella Annesi-Maesano; Jean-Jacques Braun; Bertrand Delaisi; Thierry Haddad; Olivier Malard; Florence Trébuchon; Elie Serrano
Journal:  Clin Transl Allergy       Date:  2013-02-18       Impact factor: 5.871

4.  A survey of clinical features of allergic rhinitis in adults.

Authors:  Franco Frati; Ilaria Dell'Albani; Giovanni Passalacqua; Sergio Bonini; Oliviero Rossi; Gianenrico Senna; Cristoforo Incorvaia
Journal:  Med Sci Monit       Date:  2014-11-04

5.  Symptomatology Patterns in Children with Allergic Rhinitis.

Authors:  Michael Katotomichelakis; Theodoros Iliou; Ioannis Karvelis; Evangelos Giotakis; Gerasimos Daniilides; Eleni Erkotidou; Christos Lazaridis; George K Anastassopoulos
Journal:  Med Sci Monit       Date:  2017-10-16

6.  Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of 'reboot' surgery.

Authors:  Luca Malvezzi; Francesca Pirola; Armando De Virgilio; Enrico Heffler
Journal:  BMJ Case Rep       Date:  2020-04-02

7.  Reduced work/academic performance and quality of life in patients with allergic rhinitis and impact of allergen immunotherapy.

Authors:  A Roger; E Arcalá Campillo; M C Torres; C Millan; I Jáuregui; E Mohedano; S Liñan; P Verdu; N Rubira; M Santaolalla; P González; A Orovitg; E Villarrubia
Journal:  Allergy Asthma Clin Immunol       Date:  2016-08-11       Impact factor: 3.406

8.  Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort.

Authors:  R Muñoz-Cano; P Ribó; G Araujo; E Giralt; J Sanchez-Lopez; A Valero
Journal:  Clin Transl Allergy       Date:  2018-07-09       Impact factor: 5.871

9.  Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.

Authors:  Ranbir Kaulsay; Duc Tung Nguyen; Hans Christian Kuhl
Journal:  Immun Inflamm Dis       Date:  2018-10-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.